EN    EN  
 EUROPEAN COMMISSION 
Brussels, XXX   
SANCO/7006/2012-Rev. 1 
[…](2012) XXX  draft 
  
COMMISSION IMPLEMENTING DECISION 
of XXX  
amendin g Decision 2010/472/EU on imports of semen, ova and embr yos of animals of the 
ovine and caprine species into the Union 
(Text with EEA relevance )   
EN 1   EN COMMISSION IMPLEMENTING DECISION 
of XXX  
amending Decision 2010/472/EU on imports of semen, ova an d embryos of animals of the 
ovine and caprine species into the Union 
(Text with EEA relevance) 
THE EUROPEAN COMMISSION, 
Having regard to the Treaty on the Functioning of the European Union, Having regard to Council Dire ctive 92/65/EEC of 13 July 1992 laying down animal health 
requirements governing trade in and imports into  the Community of animals, semen, ova and 
embryos not subject to animal health require ments laid down in specific Community rules 
referred to in Annex A( I) to Directive 90/425/EEC
1, and in particular Article 17(2)(b), the 
first indent of Article 18(1), and the introduc tory phrase and point (b ) of Article 19 thereof,  
Whereas: (1) Commission Decision 2010/472/EU of 26 A ugust 2010 on imports of semen, ova and 
embryos of animals of the ovine an d caprine species into the Union
2 sets out the lists 
of third countries from which Member Stat es are to authorise imports of semen, ova 
and embryos of domestic animals of the ovine and caprine species and additional 
guarantees as regards specific animal diseases  to be provided by cer tain third countries 
listed in Annexes I and III thereto and establishes the model health certificates for such imports in Part 2 of Annex II and Pa rt 2 of Annex IV to that Decision. 
(2) The current animal health requriements for bluetongue in the model health certificates 
in Part 2 of Annex II and Part 2 of A nnex IV to Decision 2010/472/EU require that 
donor animals fulfil the import conditions for ovine and caprine semen, ova and embryos laid down in the Bluetongue Chapte r of the Terrestrial Animal Health Code 
of the World Organisation for animal Hea lth (OIE). That Chapter recommends a 
whole range of risk mitigating measures aiming at either protecting the mammalian 
host from exposure to the infectious vector  or through the inactivation of the virus by 
antibodies. 
(3) In addition, the OIE has laid down a Chapter on Surveillance for arthropod vectors of 
animal diseases in the Terrestrial Animal  Health Code. Those recommendations do not 
include the monitoring of rumi nants for antibodies to Simbu viruses, such as Akabane 
and Aino viruses of the Bunyaviridae  family, which used to be considered an 
economic method for determining the distri bution of bluetongue competent vectors 
until more information on the spread of those diseases became available. 
                                                
 
1 OJ L 268, 14.9.1992, p. 54.  
2 OJ L 228, 31.8.2010, p. 74.  
EN 2   EN (4) Since moreover the OIE does not list Akaban e and Aino diseases in the Terrestrial 
Animal Health Code, the requ irement for annual testing for those diseases to prove 
absence of the vector should be deleted from Annexes I and III to Decision 2010/472/EU and the model health certificates in Part 2 of Annex II and Part 2 of 
Annex IV to that Decision. 
(5) In addition, the conditions for epizootic haemorrhagic disease in model health 
certificates in Part 2 of Annex II and Part  2 of Annex IV to Decision 2010/472/EU are 
currently not entirely consistent with those set out respectively in Commisssion 
Implementng Decision 2011/630/EU of 20 Se ptember 2011 on imports into the Union 
of semen of domestic animals of the bovine species
3 and in the Manual of Diagnostic 
Tests and Vaccines for Terrestrial Animals of the OIE. As a result, those model health 
certificates  should be amended to take acc ount of the provisions in that Decision and 
the recommendations in that Manual. 
(6) The Annexes to Decision 2010/472/EU s hould therefore be amended accordigly. 
(7) To avoid any disruption of trade, the use of  health certificates issued in accordance 
with Decision 2010/472/EU applying until 31 December 2012 should be authorised 
during a transitional period subject to certain conditions. 
(8) The measures provided for in this Decision are in accordance with the opinion of the 
Standing Committee on the Food Chain and Animal Health, 
HAS ADOPTED THIS DECISION: 
Article 1 
The Annexes to Decision 2010/472/EU are replaced  by the text in the A nnex to this Decision. 
Article 2 
For a transitional period until 30 June 2013, Member States shall authorise imports from third 
countries of: 
(a) semen and stocks of semen of animals of the ovine and capr ine species which are 
accompanied by a health certificate issued not later than 31 May 2013 in accordance 
with the model set out in Section A of Part 2 of Annex II to Decision 2010/472/EU 
applying until 31 December 2012. 
(b) ova and embryos and stocks of ova and em bryos of animals of the ovine and caprine 
species accompanied by a heal th certificate issued not  later than 31 May 2013 in 
accordance with the model set out in Part 2 of Annex VI to Decision 2010/472/EU applying until 31 December 2012. 
                                                
 
3 OJ L 247, 24.9.2011, p. 32.  
EN 3   EN Article 3 
This Decision shall apply from 1 January 2013.  
Article 8 
This Decision is addressed to the Member States. 
Done at Brussels,  
 For the Commission 
 John DALLI  Member of the Commission  
EN 4   EN ANNEX  
(1) Annex I is replaced by the following: 
"ANNEX I  
List of third countries or parts thereof from wh ich Member States are to authorise imports of 
consignments of semen of animals of the ovine and caprine species  
Remarks 
ISO Code Name of the third 
country Description of the territory  
(if appropriate ) Additional guarantees 
AU Australia  The additional guarantees as regards testing 
set out in point II.4.9.1. of the health 
certificate set out in Section A of Part 2 of 
Annex II are compulsory. 
CA Canada  Territory as described in Part 1 of 
Annex I to Commission 
Regulation (EU) No 206/2010. The additional guarantee as regards testing 
set out in point II.4.9.1. of the health 
certificate set out in Section A of Part 2 of 
Annex II is compulsory. 
CH Switzerland (*)   
CL Chile   
GL Greenland   
HR Croatia   
IS Iceland   
NZ New Zealand    
PM Saint Pierre and 
Miquelon   
US United States  The additional guarantee as regards testing 
set out in point II.4.9.1. of the health certificate set out in Section A of Part 2 of 
Annex II is compulsory. 
(*) Certificates in accordance with th e Agreement between the European Co mmunity and the Swiss Confederation 
on trade in agricultural products as approved by Deci sion 2002/309/EC, Euratom of the Council, and of the 
Commission as regards Agreement on Scientific a nd Technological Cooperation of 4 April 2002 on the 
conclusion of seven Agreemen ts with the Swiss Federation (OJ L 114, 30.4.2002, p. 132).  
EN 5   EN (2) In Part 2 of Annex II, Sec tion A is replaced by the following: 
"Section A  
Model 1 - Health certificate for semen dispatch ed from an approved se men collection centre 
of origin of the semen 
COUNTRY:  Veterinary certificate to EU  
I.2. Certificate reference No I.2.a. 
I.3. Central competent authority I.1. Consignor 
 Name 
 Address 
 
 Tel. I.4. Local competent authority 
I.5. Consignee 
 Name 
 Address 
 
 Postal code  Tel. I.6. Person responsible for the load in EU 
 Name 
 Address 
 
 Postal code  Tel.  
I.7. Country of 
origin  ISO code I.8. Region of origin Code I.9. Country of 
destination ISO code  I.10. Region of 
destination Code 
        
I.11. Place of origin 
  Name Approval number 
 Address  Name Approval number  Address 
 Name Approval number 
 Address I.12. Place of destination 
  Name 
 Address   Postal code Part I : Details of di spatched consignment 
I.13. Place of loading I. 14. Date of departure 
I.16. Entry BIP in EU 
   I.15. Means of transport 
  Aeroplane  Ship  Railway wagon  
 Road vehicle  Other  
 Identification 
 Documentary references I.17. 
 I.19. Commodity code (HS code) 
05 11 99 85  I.18. Description of commodity 
 I.20. Quantity 
 I.21.  I.22. Number of packages 
 I.23. Seal/Container No I.24.  
 I.25. Commodities certified for: 
  Artificial reproduction  
 
 I.26. For transit through EU to third country  
 
 Third country ISO code  I.27. For import or admission into EU  
 I.28. Identification of the commodities  
  Species (Scientific name) Breed Donor identity Date of collection Approval numb er of the centre Quantity 
     
EN 6   EN  COUNTRY Ovine and caprine semen - Section A  
 II. Health information II.a. Certificate reference No II.b. 
 Part II: Certification 
 
 
 
 I, the undersigned, official vete rinarian, hereby certify that: 
II.1. The exporting country …………………………………………………………………… 
(name of exporting country )(2) 
II.1.1. has been free from rinderpes t, peste des petits ruminants,  sheep and goat pox, contagious 
caprine pleuropneumonia and Rift Valley fe ver during the 12 months immediately prior 
to collection of the semen to be exported and up until its date of dispatch and no 
vaccination against th ese diseases took plac e during that period; 
II.1.2. has been free from foot-and-mouth dis ease during the 12 months immediately prior to 
collection of the semen to be exported a nd up until its date of dispatch and no 
vaccination against th is disease took place during that period. 
II.2. The centre described in Box I.11 and at which the semen to be exported was collected and stored: 
II.2.1. meets the conditions laid down in Ch apter I(I)(1) of Annex D to Directive 92/65/EEC; 
II.2.2. is operated and supervised in accord ance with the conditions laid down in 
Chapter I(II)(1) of Annex D to Directive 92/65/EEC. 
II.3. The ovine/caprine(1) animals standing at the semen collection centre: 
II.3.1. prior to their stay in the quarant ine accommodation described in point II.3.3., 
(1)(4)either  [II.3.1.1. originate from the territory described in Box I.8, which has been recognised as officially 
brucellosis ( B. melitensis )-free,] 
(1)or [II.3.1.1. have belonged to a hol ding which has obtained and maintain ed its officially brucellosis 
(B. melitensis )-free status in accordance with Directive 91/68/EEC,] 
(1)or [II.3.1.1. originate from a holding, where in respect of brucellosis ( B. melitensis ) all susceptible 
animals have been free from clinical or any si gns of this disease for the last 12 months, 
none of the ovine and caprine animals have be en vaccinated against this disease, save 
those vaccinated with Rev. 1 vaccine more th an two years ago, and all ovine and caprine 
animals over six months of age have b een subjected to at least two tests(3), carried out 
with negative results on samples taken on ……………. ( date) and on …………. ( date) 
at least six months apart, the latter being within 30 days of entry into the quarantine 
accommodation,] 
and have not been kept previously in a holding of a lower status;  
II.3.1.2. have been kept continuously for at  least 60 days on a holding where no case of 
contagious epididymitis ( Brucella ovis ) has been diagnosed in the last 12 months, 
(1)and [they are animals of the ovine  species and have undergone during the 60 days prior to 
their stay in the quarantine accommodation described in point II.3.3. a complement 
fixation test, or any other test with an equivalent documented sensitivity and specificity, 
to detect contagious epididymitis with  result of less than 50 ICFTU/ml;] 
II.3.1.3. to the best of my knowledge do not co me from holdings and have not been in contact 
with animals of a holding, in which based on the official notification system and 
according to the written declaration made by the owner any of the following diseases has 
been clinically detected within the stated periods prior to their stay in the quarantine 
accommodation described in point II.3.3.: 
(a) contagious agalactia of sheep or goats ( Mycoplasma agalactiae, Mycoplasma 
capricolum, Mycoplasma mycoides var. mycoides " large colony"), within the last 
six months, 
(b) paratuberculosis and caseous lym phadenitis, within the last 12 months, 
(c) pulmonary adenomatosis, within the last three years;  
(1)either  [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the 
last three years;] 
(1)or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the 
last 12 months, and all the infected an imals were slaughtered and remaining 
animals subsequently reacte d negatively to two tests carried out at least six 
months apart;] 
II.3.2. They have undergone, the following tests carried out on a blood sample collected within 
the 28 days preceding the commencement of th e period of quarantine specified in point 
II.3.3.for:  
EN 7   EN  COUNTRY Ovine and caprine semen - Section A  
 II. Health information II.a. Certificate reference No II.b. 
– brucellosis ( B. melitensis ), with negative results in each case in accordance with 
Annex C to Directive 91/68/EEC; 
– contagious epididymitis ( B. ovis ), in the case of sheep only, with negative results 
in each case in accordance with Annex D to Directive 91/68/EEC, or any other 
test with an equivalent documented sensitivity and specificity; 
– border disease in accordance with point 1.4 (c) of Chapter II(II) of Annex D to 
Directive 92/65/EEC; 
II.3.3. have satisfied the quarantine isolation period of at least 28 days in a quarantine 
accommodation specifically approved for the purpose by the competent authority and during this period 
II.3.3.1. only animals of at least the same health status were present in the quarantine 
accomodation; 
II.3.3.2. the animals have under gone the tests, carried out by the laboratory approved by the 
competent authority of the exporting country on samples taken not earlier than 21 days 
after the animals were admitted to the quarantine accomodation, for: 
– brucellosis ( B. melitensis ) with negative results in accordance with Annex C to 
Directive 91/68/EEC; 
– contagious epididymitis ( Brucella ovis ), in the case of sheep only, with negative 
results in accordance with Annex D to Dir ective 91/68/EEC, or any other test with 
an equivalent documented se nsitivity and specificity; 
– border disease in accordance with point 1.6 of Chapter II(II) of Annex D to 
Directive 92/65/EEC; 
II.3.4. have undergone at least once a year th e routine tests with negative results for: 
– brucellosis ( B. melitensis ) in accordance with Annex C to Directive 91/68/EEC; 
– contagious epididymitis ( Brucella ovis)  in accordance with Annex D to Directive 
91/68/EEC, or any other test with an equivalent documented sensitivity and 
specificity; in the case of sheep only; 
– border disease in accordance with point 5(c) of Chapter II(II) of Annex D to 
Directive 92/65/EEC. 
II.4. The semen to be exported wa s obtained from donor rams/bucks
(1) which: 
II.4.1. were admitted to the approved semen collection centre with the express permission of 
the centre veterinarian. 
II.4.2. show no clinical signs of disease on the day of admission to the approved semen 
collections centre and on the day the semen was collected; 
(1)either  [II.4.3. have not been vaccinat ed against foot-and-mouth disease during the 12 months prior to 
collection of the semen;] 
(1)or [II.4.3. have been vaccinated against foot-a nd-mouth disease at least 30 days prior to the 
collection, and 5 % (with a minimum of five straws) of each collection have been 
submitted to a virus isolation test for foot -and-mouth disease with negative results;] 
II.4.4. have been kept at an approved semen coll ection centre for a conti nuous period of at least 
30 days immediately prior to collection of the semen, in the case of collections of fresh 
semen; 
II.4.5. have not served naturally after their en try to the quarantine accommodation described in 
point II.3.3. and up to and includ ing the day of semen collection; 
II.4.6. have been kept at the a pproved semen collection centres:  
II.4.6.1. which have been free from foot-and-mout h disease for at least three months prior to 
collection of the semen and 30 days after coll ection or, in the case of  fresh semen, until 
the date of dispatch, and which are situated in the centre of an area of 10 kilometres 
radius in which there has been no case of f oot-and-mouth disease for at least 30 days 
prior to collection of the semen; 
II.4.6.2. which have been free, during the pe riod commencing 30 days prior to collection and 
ending 30 days after collection of the semen or, in the case of fresh semen, until the date 
of dispatch, from brucellosis ( B. melitensis ), contagious epididymitis ( B. ovis ), anthrax  
EN 8   EN  COUNTRY Ovine and caprine semen - Section A  
 II. Health information II.a. Certificate reference No II.b. 
and rabies; 
(1)either  [II.4.7. have remained in the exporting country for at least the past six m onths prior to collection 
of the semen to be exported;] 
(1)or [II.4.7. during the past six months prior to co llection of the semen they satisfied the animal 
health conditions applying to donors of the semen which is intended for export to the 
European Union and they have been imported into the exporting country at least 30 days 
prior to collection of the semen from ………………………….(2);] 
(1)either  [II.4.8. were kept in a bluetongue virus-free coun try or zone for at least 60 days prior to, and 
during, collection of the semen;] 
(1)or [II.4.8. were kept during a bluetongue virus s easonally free period in a seasonally free zone for 
at least 60 days prior to, and during collection of the semen;] 
(1)or [II.4.8. were kept protected from Culicoides  for at least 60 days prio r to, and during collection of 
the semen;] 
(1)or [II.4.8. underwent a serological test to detect antibodies to the bluetongue virus group, carried 
out in accordance with the Manual of Diagnos tic Tests and Vaccines for Terrestrial 
Animals, with negative results, at least ev ery 60 days throughout the collection period 
and between 21 and 60 days after collection of the semen;] 
(1)or [II.4.8. underwent an agent identification test fo r bluetongue virus, carried out in accordance 
with the Manual of Diagnostic Tests and Vacci nes for Terrestrial Animals with negative 
results on blood samples taken on the day of semen collection and at  least every 7 days 
(virus isolation test) or at least every 28 days (PCR test) during the semen collection and 
have been protected from Culicoides  during collection of the semen;] 
II.4.9. were resident in the exporting country, 
(1)(5)either [II.4.9.1. which according to official findings is  free from epizootic haemor rhagic disease (EHD);] 
(1)or [II.4.9.1. in which according to official findings the following serotypes of epizootic 
haemorrhagic disease (EHD) exis t: …………………… and were subjected with 
negative results in each case to: 
(1)either [on two occasions not more than 12 months apart in a serological test(6) carried out in an 
approved laboratory on samples of blood take n prior to and not less than 21 days 
following collection for this consigment of semen.]] 
(1)or [a serological test(4) for the detection of antibody to the EHDV group, carried out on 
samples taken at intervals of  not more than 60 days throughout the collection period and 
between 21 and 60 days after the final coll ection for this consignment of semen.]] 
(1)or [an agent identification test(4) carried out in approved laboratories on blood samples 
collected at commencement and conclusion of, and at least every 7 days (virus isolation test) or at least every 28 days (PCR test) during collection for this consignment of 
semen.]] 
II.5. The semen to be exported: 
II.5.1. was collected after the date on which the centre was approved by the competent 
authority of the exporting country; 
II.5.2. was collected, processed, preserved, stor ed and transported in accordance with Chapter 
III(I) of Annex D to Directive 92/65/EEC; 
(1)either  [II.5.3. meets the requirements of Chapter A (I) of Annex VIII to Regulation (EC) No 999/2001;] 
(1)or [II.5.3. meets the requirements of Chapter A (I) of Annex VIII to Regulation (EC) No 999/2001 
and is destined for a Member State which benefits, for all or part of its territory, from the provisions laid down in point (b) or (c) of  Chapter A(I) of Annex VIII to Regulation 
(EC) No 999/2001 and the donor animals comply  regarding scrapie with the guarantees 
provided for by the programmes referred to  in that point and with the guarantees
(7) 
requested by the Member State of destination;] 
II.5.4. was sent to the place of loading in a sealed container in accordance with point 1.4 of 
Chapter III(I) of Annex D to Directive 92/65 /EEC and bearing the number indicated in 
Box I.23. 
(1)either  [II.6. No antibiotics were added to the semen.] 
(1)or [II.6. The following antibiotic or combination of antibiotics was added to produce a  
EN 9   EN  COUNTRY Ovine and caprine semen - Section A  
 II. Health information II.a. Certificate reference No II.b. 
concentration in the final diluted semen of not less than(8): 
……………………………………………………………. .] 
Notes 
Part I: 
Box I.6.: Person responsible for the load in EU : this box is to be filled in only if it is a certificate for transit 
commodity 
Box I.11.: Place of origin  shall correspond to the approved semen co llection centre in which the semen was 
collected and listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the Commission 
website: http://ec.europa.eu/food/anima l/semen_ova/ovine/index_en.htm . 
Box I.22.: number of packages shall correspond to the number of containers. 
Box I.23.: identification of container and seal number shall be indicated. 
Box I.26.: fill in according to whether it is a transit or an import certificate. Box I.27.: fill in according to whether it is a transit or an import certificate. 
Box I.28.: Species : select amongst “ Ovis aries ” and “ Capra hircus ” as appropriate.  
 Donor identity  shall correspond to the official  identification of the animal. 
 Date of collection  shall be indicated in the following format: dd/mm/yyyy. 
 Approval number of the centre  shall correspond to the approval numb er of the semen collection centre 
indicated in Box I.11. 
Part II: 
(1) Delete as necessary. 
(2) Only third countries listed in Annex I to Decision 2010/472/EU. 
(3) Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC. 
(4) Only for the territory appearing with the entry "V " in column 6 of Part 1 of Annex I to Commission 
Regulation (EU) No 206/2010 [OJ L 73, 20 .3.2010, p. 1.] as last amended. 
(5) See remarks for exporting country concer ned in Annex I to Decision 2010/472/EU. 
(6) Standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the Manual of Diagnostic 
Tests and Vaccines for Terrestrial Animals. 
(7) Additional guarantees as laid down in Article 2 of  Regulation (EC) No 546/2006 [OJ L 94, 1.4.2006, p.28]. 
(8) Insert names and concentrations. 
• The signature and the stamp must be in a different colour to that of the printing. 
 Official veterinarian  
 Name (in capital letters): Qualification and title: 
 Date: Signature:  Stamp: 
" 
EN 10   EN (3) Annex III is replaced by the following: 
"ANNEX III  
List of third countries or parts thereof from which Member States are to authorise 
imports of consignments of ova and embryos of  animals of the ovine and caprine species  
Remarks 
ISO Code Name of the 
third country Description of the territory 
(if appropriate ) Additional guarantees 
AU Australia  The additional guara ntees as regards 
testing set out in point II.2.6.1. of the 
health certificate set out in Part 2 of 
Annex IV are compulsory. 
CA Canada  Territory as described in Part 1 of 
Annex I to Commission 
Regulation (EU) No 206/2010 as 
last amended. The additional guarantee as regards 
testing set out in point II.2.6.1. of the 
health certificate set out in Part 2 of 
Annex IV is compulsory. 
CH Switzerland (*)   
CL Chile    
GL Greenland    
HR Croatia    
IS Iceland    
NZ New Zealand    
PM Saint Pierre and 
Miquelon    
US United States   The additional guarantee as regards 
testing set out in point II.2.6.1. of the 
health certificate set out in Part 2 of 
Annex IV is compulsory. 
(*) Certificates in accordance with the Agreement between the European Community and the Swiss Confederation on 
trade in agricultural products as approved by Deci sion 2002/309/EC, Euratom of the Council, and of the 
Commission as regards Agreement on Scientific and Tec hnological Cooperation of 4 April 2002 on the conclusion 
of seven Agreements with the Swiss Federation (OJ L 114, 30.4.2002, p. 132).   
EN 11   EN (4) Part 2 of Annex IV is  replaced by the following: 
"Part 2 
MODEL HEALTH CERTIFICATE FOR IM PORTS OF CONSIGMENTS OF OVA 
AND EMBRYOS OF ANIMALS OF TH E OVINE AND CAPRINE SPECIES  
COUNTRY:  Veterinary certificate to E U
I.2. Certificate reference No I.2.a. 
I.3. Central competent authority I.1. Consignor 
 Name 
 Address 
 
 Tel. I.4. Local competent authority 
I.5. Consignee 
 Name 
 Address 
 
 Postal code  Tel. I.6. Person responsible for the load in EU 
 Name 
 Address 
 
 Postal code 
 Tel.  
I.7. Country of 
origin  ISO code I.8. Region of origin Code I.9. Country of 
destination ISO code  I.10. Region of 
destination Code 
        
I.11. Place of origin 
  Name Approval number 
 Address  Name Approval number  Address 
 Name Approval number 
 Address I.12. Place of destination 
  Name 
 Address   Postal code Part I : Details of di spatched consignment 
I.13. Place of loading I. 14. Date of departure 
I.16. Entry BIP in EU 
   I.15. Means of transport 
  Aeroplane  Ship  Railway wagon  
 Road vehicle  Other  
 Identification 
 Documentary references I.17. 
 I.19. Commodity code (HS code) 
05 11 99 85  I.18. Description of commodity 
 I.20. Quantity 
 I.21.  I.22. Number of packages 
 I.23. Seal/Container No I.24.  
 I.25. Commodities certified for: 
  Artificial reproduction  
 
 I.26. For transit through EU to third country  
 
 Third country ISO code  I.27. For import or admission into EU  
 I.28. Identification of the commodities 
 
Species(Scientific name) Breed Category Donor  identity Date of collection Date of fr eezing Approval number of the team Quantity  
 
  
EN 12   EN  COUNTRY Ovine and caprine ova/embryos  
 II. Health information II.a. Certificate reference No II.b. 
 Part II: Certification 
 
 
 
 I, the undersigned, official vete rinarian, hereby certify that: 
II.1. The exporting country ……………………………………………………………………….. 
(name of exporting country )(2) 
II.1.1. has been free from rinderpest, peste des petits ruminants, sheep and goat pox, contagious 
caprine pleuropneumonia, and Rift Valley fe ver during the 12 months immediately prior to 
collection of the ova/embryos(1) to be exported and up until its date of dispatch and no 
vaccination against th ese diseases took plac e during that period; 
(1)either  [II.1.2. has been free from foot-and-mouth dis ease during the 12 months immediately prior to 
collection of the ova/embryos(1) and did not carry out vaccin ation against foot-and-mouth 
disease during that period;] 
(1)or [II.1.2. has not been free from foot and mouth disease during the 12 months immediately prior to 
collection of the ova/embryos(1) and/or carried out vaccination against foot-and- mouth 
disease during that period and  the donor females come from holdings on which no animal 
was vaccinated against foot-and-mouth diseas e during 30 days prior to collection and no 
animal of susceptible species showed clinic al signs of foot-and-mouth disease during the 
30 days prior to, and at least 30 days after, the ova/embryos(1) were collected and the 
ova/embryos(1) were not subjected to penetration of zona pellucida ;] 
II.2. The ova/embryos(1) to be exported:  
II.2.1. were collected/produced(1) and processed on premises within a 10-km radius of which there 
was no incidence of foot-and-mouth disease, vesi cular stomatitis, Rift Valley fever in the 
30 days immediately prior to their collection; 
II.2.2. were stored at all times on approved premises within a 10-km  radius of which there was no 
incidence of foot-and-mouth disease, vesicular stomatitis or Rift Valley fever from the time of their collection until  30 days thereafter; 
II.2.3. were collected/produced
(1) by the team described in Box I.11, which has been approved and 
supervised in accordance with Chapter I(III)  of Annex D to Directive 92/65/EEC; 
II.2.4. meet the requirements of Chapter III(II)of Annex D to Directive 92/65/EEC; 
II.2.5. come from the donor  females of ovine/caprine(1) species which: 
(1)either  [II.2.5.1. were kept in a bluetongue  virus-free country or zone for at least 60 days prior to, and during 
collection of the ova/embryos(1);] 
(1)or [II.2.5.1. were kept during a bluetongue virus s easonally free period in a seasonally free zone;] 
(1)or [II.2.5.1. were kept protected from Culicoides  for at least 60 days prior to, and during the collection 
of the ova/embryos(1);] 
(1)or [II.2.5.1. underwent a serological test to detect an tibodies to the bluetongue virus group, carried out 
in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 
between 21 and 60 days after collection of the ova/embryos(1) and giving negative results;] 
(1)or [II.2.5.1. underwent an agent identification test for bluetongue virus, carried out in accordance with 
the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample 
taken on the day of the ova/embryos(1) collection or the day of slaughtering and giving 
negative results;] 
II.2.5.2. to the best of my knowledge do not come from holdings and have not been 
in contact with animals of a holding, in which based on the official notification 
system and according to the written declaration made by the owner, in which any of the following diseases has been clinically de tected within the stated periods prior to 
collection of the ova/embryos
(1) to be exported:(a) contagious agalactia of sheep or 
goats ( Mycoplasma agalactiae, Mycoplasma capr icolum, Mycoplasma mycoides var. 
mycoides "large colony"), within the last six months; 
(b) paratuberculosis and caseous lym phadenitis, within the last 12 months; 
(c) pulmonary adenomatosis, within the last three years; 
(1)either [(d) Maedi/Visna for sheep or caprine viral arth ritis/encephalitis for goats, within the last 
three years;] 
(1)or [(d) Maedi/Visna for sheep or caprine viral ar thritis/encephalitis for goats, within the last 
12 months, and all the infected animals were slaughtered and remaining animals 
subsequently reacted negatively to two test s carried out at leas t six months apart;]  
EN 13   EN  COUNTRY Ovine and caprine ova/embryos  
 II. Health information II.a. Certificate reference No II.b. 
II.2.5.3. showed no clinical signs of  disease on the day of the ova/embryos(1) collection; 
(1)(4)either  [II.2.5.4. originate from the territo ry described in Box I.8, which ha s been recognised as officially 
brucellosis (B. melitensis) -free, and] 
(1)or [II.2.5.4. have belonged to a hol ding which has obtained and maintain ed its officially brucellosis 
(B. melitensis) -free status in accordance with Directive 91/68/EEC, and] 
(1)or [II.2.5.4. originate from a holding, where in respect of brucellosis ( B. melitensis ) all susceptible 
animals have been free from clinical or any signs  of this disease for the last 12 months, none 
of the ovine and caprine animals have been vaccinated against this disease, save those 
vaccinated with Rev. 1 vaccine more than two years ago, and all ovine and caprine animals 
over six months of age have been subjected to at least two tests(3), carried out with negative 
results on samples taken on ……………. ( date) and on …………. ( date) at least six months 
apart, the latter being within 30 days prior to collection of the ova/embryos(1),] 
and have not been kept previously in a holding of a lower status;  
(1)either  [II.2.5.5. have remained in the exporting country for at least the past six mont hs prior to collection of 
the ova/embryos(1) to be exported;] 
(1)or [II.2.5.5. during the past six months prior to collection of the ova/embryos(1) they satisfied the animal 
health conditions applying to donors of the ova/embryos(1) which are intended for export to 
the European Union and they have been importe d into the exporting country at least 30 days 
prior to collection of the ova/embryos(1) from ………………………….(2);] 
[II.2.6. were collected/produced(1) in the exporting country, 
(1)either  [II.2.6.1 which according to official findings is  free from epizootic haemor rhagic disease (EHD);] 
(1)(5)or [II.2.6.1 in which according to official findings the following serotypes of epizootic haemorrhagic 
disease (EHD) exist: …………………… and were subj ected with negative results in each 
case to: 
(1)either  [on two occasions not more than 12 months apart in a serological test(6) carried out in an 
approved laboratory on samples of blood taken pr ior to and not less than 21 days following 
collection for this consigment of ova/embryos(1);] 
(1)or [a serological test(4) for the detection of antibody to the EHDV group, carried out on 
samples taken at intervals of not more than  60 days throughout the collection period and 
between 21 and 60 days after the final collect ion for this consignment of ova/embryos(1);]] 
(1)or [an agent identification test(4) carried out in approved laboratories on blood samples 
collected at commencement and conclusion of, and at least every 7 days (virus isolation 
test) or at least every 28 days (PCR test) during collection for this consignment of 
ova/embryos(1);]] 
(1)either  [II.2.8. meet the requirements of Chapter A (I) of Annex VIII to Regulation (EC) No 999/2001;] 
(1)or [II.2.8. meet the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 and 
are destined for a Member State which benefits , for all or part of its territory, from the 
provisions laid down in point (b) or (c) of Chapter A(I) of Annex VIII to Regulation (EC) 
No 999/2001 and the donor animals comply regard ing scrapie with the guarantees provided 
for by the programmes referred to in that point and with the guarantees(7) requested by the 
Member State of destination;] 
II.2.9. were collected/produced(1) after the date on which the embr yo collection team was approved 
by the competent authority of the exporting country; 
II.2.10. were processed and stored  under approved conditions for at least 30 days immediately after 
their collection/production(1) and transported under conditions which satisfy the terms laid 
down in Chapter III(II) of Annex D to Directive 92/65/EEC; 
II.2.11. were sent to the place of loading in a sealed container in accordance with point 6 of 
Chapter III(II) of Annex D to Directive 92/ 65/EEC and bearing the number detailed in 
Box I.23. 
(9) II.2.12. were conceived by artificial insemination/as a result of in vitro  fertilisation(1) using semen 
coming from semen collection centres . 
(1)either  [II.12.1. approved in accordance with Article 11(2)  of Directive 92/65/EEC a nd located in a Member 
State of the European Union; and the semen complies with the requirements of Directive 
92/65/EEC.]  
EN 14   EN  COUNTRY Ovine and caprine ova/embryos  
 II. Health information II.a. Certificate reference No II.b. 
(1)or [II.12.1. approved in accordance with Article 17(3 )(b) of Directive 92/65/EEC and located in a third 
country listed listed in Annex I to Decisi on 2010/472/EU, and the semen complies with the 
requirements set out in Part 2 of Annex II to that Decision.] 
Notes 
Part I: 
Box I.6.: Person responsible for the load in EU : this box is to be filled in only if it is a certificate for 
transit commodity. 
Box I.11.: Place of origin  shall correspond to the approved em bryo collection team or embryo 
production team by which the ova/embryos were  collected/produced, processed and stored; 
and listed in accordance with Article 17(3 )(b) of Directive 92/65/EEC on the Commission 
website: http://ec.europa.eu/food/anima l/semen_ova/ovine/index_en.htm . 
Box I.22.: number of packages shall correspond to the number of containers. 
Box I.23.: identification of container and seal number shall be indicated. 
Box I.26.: fill in according to whether it is a transit or an import certificate. Box I.27.: fill in according to whether it is a transit or an import certificate. 
Box I.28.: S pecies : select amongst “ Ovis aries ” and “ Capra hircus ” as appropriate. 
 Category : specify if in vivo  derived embryos, in vivo  derived ova, in vitro  produced embryos 
or micromanipulated embryos. 
 Donor identity  shall correspond to the official  identification of the animal. 
 Date of collection  shall be indicated for in vivo  derived embryos and in the following format: 
dd/mm/yyyy. 
 Date of freezing  shall be indicated in the following format: yy/mm/dd. 
 Approval number of the team : shall correspond to the approv ed embryo collection team or 
embryo production team by which the ova/emb ryos were collected/p roduced, processed and 
stored; and listed in accordance with Arti cle 17(3)(b) of Directive 92/65/EEC on the 
Commission website: http://ec.europa.eu/ food/animal/semen_ova /ovine/index_en.htm
. 
Part II: 
(1) Delete as appropriate. 
(2) Only third countries listed in Annex I to Decision 2010/472/EU. (3) Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC. 
(4) Only for the territory appearing with the entry "V " in column 6 of Part 1 of Annex I to Commission 
Regulation (EU) No 206/2010 [OJ L 73, 20.3.2010] as last amended. 
(5) See remarks for exporting country conc erned in Annex III to Decision 2010/472/EU. 
(6) Standards for EHD virus diagnos tic tests are described in the Bluetongue Chapter of the Manual of 
Diagnostic Tests and Vaccines  for Terrestrial Animals. 
(7) Additional guarantees as laid down  in Article 2 of Regul ation (EC) No 546/2006 [OJ L 94, 1.4.2006, p.28]. 
(8) Only approved semen collection centres listed in ac cordance with Article 11(4)  and Article 17(3)(b) of 
Directive 92/65/EEC on the Commission websites: 
http://ec.europa.eu/food/anim al/approved_establishments/estab lishments_vet_field_en.htm
; 
http://ec.europa.eu/food/anim al/semen_ova/ovine/index_en.htm . 
(9) Does not apply to ova. 
• The signature and the stamp must be in a different colour to that of the printing. 
 Official veterinarian  
 Name (in capital letters): Qualification and title: 
 Date: Signature: 
 Stamp: 
"